Fri.Aug 23, 2024

article thumbnail

Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub: reports

Fierce Pharma

Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.

307
307
article thumbnail

Paige Launches AI Tool that Screens 505 Genes for Improved Cancer Diagnosis

MedCity News

AI startup Paige launched an AI-powered biomarker module that the company says can evaluate more than 505 genes and identify 1,228 molecular biomarkers from standard pathology slides. The post Paige Launches AI Tool that Screens 505 Genes for Improved Cancer Diagnosis appeared first on MedCity News.

Biopharma 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA signs off on Modena, Pfizer/BioNTech's adapted vaccines to corral elusive COVID virus

Fierce Pharma

The FDA has authorized the use of | The FDA has authorized the use of new vaccines from Pfizer/BioNTech and Moderna which have been designed to defend against the Omicron KP.2 variant of SARS-CoV-2. The nod comes as word of a new omicron variant, KP.3.1.1, is beginning to eclipse KP.2 as the dominant strain of the virus in the United States.

FDA 255
article thumbnail

How One Company Is Easing Employers’ Administrative Headaches

MedCity News

Celeste Health Solutions launched on Wednesday. The company works with employers and offers a range of point solutions and provides administrative support. The post How One Company Is Easing Employers’ Administrative Headaches appeared first on MedCity News.

104
104
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

As sales climb, Jazz's Epidiolex falls short in Japanese study in treatment-resistant epilepsies

Fierce Pharma

While some analysts figure Jazz Pharmaceuticals’ Epidiolex—sold as Epidyolex abroad—could surpass the blockbuster sales threshold by the end of the decade, the cannabidiol-based seizure drug has st | On Friday, Jazz revealed that its Epidiolex oral solution failed to mass muster in a late-stage study when used as an adjunct treatment for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS) or tuberous sclerosis complex (TSC) in young Japanese patients.

Sales 253
article thumbnail

From Adversity to Leadership: Harnessing Resilience and Empowerment Through Keynote to Transform Your Team

Scott Burrows

Keynote Speaking C.W. Driver Annual Meeting at the Discovery Cube in Santa Ana, CA As I’ve talked to many, many leaders through the years, I’ve noticed many similar traits in work styles, life experiences, and mindsets. There was a time when I would have never labeled myself as a leader in any capacity. It wasn’t until I was forced to lead myself to success, that I saw traits of leadership in myself.

More Trending

article thumbnail

From FOMO to FOMU: A Framework for Getting AI Right

MedCity News

Healthcare is a highly regulated industry, and any use of AI within it is dealing with the most sensitive data. In order to ensure you’re not putting you, your company or patients at risk, consider an evaluation framework for any AI tool that considers these three things. The post From FOMO to FOMU: A Framework for Getting AI Right appeared first on MedCity News.

article thumbnail

Fierce Pharma Asia—J&J's Tagrisso challenger; Merck's revised Kelun deal; The next biosecurity frontier

Fierce Pharma

Yuhan's Lazcluze, licensed by Johnson & Johnson, has made history as the first Korea-developed novel cancer drug to be approved by the FDA. | As part of a J&J combo, Yuhan's Lazcluze has become the first Korea-developed novel cancer drug to be approved by the FDA. Merck has optioned in on one Kelun Biotech ADC but returned another.

FDA 130
article thumbnail

Time to Get Digital in Your Practice: Improving and Making Healthcare Easier for Patients, Practices, Providers and Payors

MedCity News

Digital tools are producing a more efficient patient-centered system. Practices tuned in to the new digital world operate more smoothly, deliver higher-quality care, and allow payers to manage costs and risks more effectively. The post Time to Get Digital in Your Practice: Improving and Making Healthcare Easier for Patients, Practices, Providers and Payors appeared first on MedCity News.

article thumbnail

New COVID-19 jabs approved by FDA for 2024-25 season

pharmaphorum

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.

FDA 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Eli Lilly doubles down on Oblique partnership for antibody generation

Pharmaceutical Technology

The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.

95
article thumbnail

AstraZeneca dismisses rumours of facility relocation to US

pharmaphorum

AstraZeneca says rumours that it will relocate a planned vaccines facility from the UK to the US "do not seem to be based on facts"

110
110
article thumbnail

MHRA approves Astellas’ Vyloy combination for gastric cancer

PharmaTimes

Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms

93
article thumbnail

US immunology biotech Zenas BioPharma files $100m IPO

pharmaphorum

Zenas BioPharma has filed an initial public offering in the US seeking $100m+ for obexelimab, a therapy for rare disease IgG4-RD in phase 3

Biopharma 105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Pharma Pulse 8/23/24: Pfizer/BioNTech FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine, Hidden Obstacles in the Script-to-Therapy Journey & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Versant, Novartis team up again in hunt for another Chinook

pharmaphorum

Novartis and VC Versant set up a new biotech, Borealis Biosciences, using a similar model to an earlier alliance to create Chinook Therapeutics

110
110
article thumbnail

Association for Medical Education in Europe AMEE 2024 conference

PharmaTimes

The conference will be held in Basel, Switzerland from 26-28 August

article thumbnail

ICER says Geron's just-approved Rytelo is too pricey

pharmaphorum

ICER says Geron's new drug Rytelo for myelodysplastic syndromes (MDS) is priced three to four times higher than it should be

104
104
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Addressing Challenges to Access, Advancement of Myeloma Therapies

PharmExec

In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, MD, chief medical officer, IMF, discusses challenges of access and advancement of myeloma therapies.

Medical 52
article thumbnail

The New Penal Provisions in the Drugs and Cosmetics Act

Pharmatutor

The New Penal Provisions in the Drugs and Cosmetics Act admin Sat, 08/24/2024 - 11:28 In a bid to decriminalise and rationalise offences to further enhance trust-based governance for ease of living and doing business, the Jan Vishwas (Amendment of Provisions) Act, 2023 was published in the Gazette of India, Extraordinary, Part II – Section 1, No. 21 on the 11th August, 2023.

article thumbnail

Alzheimer’s drug milestone “bittersweet” for certain patients

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first treatment for Alzheimer’s in Great Britain that has shown some efficacy in slowing disease progression. Lecanemab is authorised to treat adults with early Alzheimer’s. It is therefore indicated for individuals with either one or no copies of the apolipoprotein E4 gene (ApoE4).

article thumbnail

From Turnover to Triumph: 70% Lower Attrition through Exceptional Leadership

ALULA

What would happen if you applied some of the best and most modern practices for improving leadership performance in a sector that has traditionally shunned this kind of investment? That was the question being asked by executives at TD Bank’s Retail Card Services, who oversee the call centers through their Merchant Solutions and Customer Service operation.

Retail 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

FDA Grants Fast Track Designation to Clarity Pharmaceuticals’ Novel Treatment for PSMA-Positive Prostate Cancer Lesions

PharmExec

64Cu-SAR-bisPSMA has demonstrated advantages over current diagnostic tools, such as higher tumor uptake, next-day imaging, and a longer half-life in PET imaging of PSMA-positive prostate cancer lesions, Clarity says.

article thumbnail

Scott Burrows: Franchise Inspirational Speaker

Scott Burrows

In the dynamic world of franchising, where both challenges and opportunities abound, Scott Burrows stands out as a truly inspirational speaker. His remarkable journey from personal adversity to achieving success across various industries provides invaluable insights for franchisees and franchisors. With a proven track record of engaging with top franchises, Scott delivers impactful messages that resonate deeply within the franchise community.

article thumbnail

Further Developing Patient Services

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Meghan Mullooly, Archbow Consulting’s Vice President, outlines the various types of available digital solutions when delivering patient services, while also sharing ways to drive efficiencies.

article thumbnail

Scott Burrows: National Association Inspirational Keynote Speaker

Scott Burrows

In a rapidly evolving world where the demands for innovation and resilience are ever-increasing, national associations are continually seeking keynote speakers who can inspire and drive transformative change. Scott Burrows stands out as a premier choice for delivering impactful and motivational speeches that resonate with diverse audiences and stimulate meaningful action.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Are we set for the revised EU GMP Annex 1?

European Pharmaceutical Review

EU GMP Annex 1 is the European Union’s guidelines for good manufacturing practice (GMP) of sterile medicinal products for human and veterinary use.1 It provides specific requirements for the manufacture of sterile medicinal products, including principles for cleanroom and clean zone design, personnel experience/qualification, and monitoring of manufacturing environments, just to name a few.

article thumbnail

Scott Burrows: Inspiring After Dinner Keynote Speaker

Scott Burrows

When it comes to after-dinner speakers who leave a lasting impact, Scott Burrows stands out as a beacon of inspiration. His story, marked by resilience and an unbreakable spirit, transforms a typical dinner event into an unforgettable experience. A Journey Beyond Adversity Scott Burrows’ journey is nothing short of extraordinary. Diagnosed as a quadriplegic, Scott faced challenges that most people would find insurmountable.

article thumbnail

FDA approves updated mRNA vaccines for Covid-19

Pharmaceutical Technology

The US FDA has approved and granted EUA for Moderna and Pfizer-BioNTech’s updated mRNA Covid-19 vaccines, Comirnaty and Spikevax.

FDA 59
article thumbnail

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Pharmacy Times

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

FDA 59
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A